Henry Nguyen
About Henry Nguyen
Henry Nguyen is a Senior Scientist I specializing in protein engineering at Asher Biotherapeutics, with a strong background in protein biochemistry and expertise in X-ray crystallography and cryo-electron microscopy. He holds a PhD in Molecular Biophysics and Biochemistry from Yale University and has contributed to significant research projects in the field.
Work at Asher Bio
Henry Nguyen serves as a Senior Scientist I in Protein Engineering at Asher Biotherapeutics, a role he has held since 2020. His work focuses on innovative research aimed at developing therapies that can significantly impact patient health. He joined Asher Bio to engage with a collaborative community dedicated to advancing biotherapeutic solutions. His contributions include research on the selective activation of the IL-2 pathway in CD8+ T cells, which targets antiviral activity against hepatitis B virus. He is also involved in optimizing the anti-tumor activity and safety of AB248.
Education and Expertise
Henry Nguyen holds a Doctor of Philosophy (PhD) in Molecular Biophysics and Biochemistry from Yale University, where he studied from 2009 to 2015. Prior to that, he earned a Bachelor of Science (BS) in Biological Sciences and Chemistry from Carnegie Mellon University from 2005 to 2009. His educational background provides a strong foundation in protein biochemistry, with expertise in techniques such as X-ray crystallography and cryo-electron microscopy. He is proficient in protein purification from various expression systems, including E. coli and S. cerevisiae.
Background
Henry Nguyen began his academic career at Carnegie Mellon University, where he completed his undergraduate studies. He then pursued graduate studies at Yale University, where he spent six years as a graduate student. Following his PhD, he worked as a Postdoctoral Scholar at UCSF from 2016 to 2020. His experience spans over a decade in protein biochemistry and molecular biology, with a focus on studying intermolecular interactions and their implications in therapeutic development.
Achievements
Throughout his career, Henry Nguyen has contributed to multiple independent and collaborative research projects, resulting in high-profile publications in the field of protein engineering and biochemistry. He has demonstrated exceptional leadership abilities through various individual and group management roles. His communication skills are evidenced by numerous presentations at scientific conferences, including participation in the Society for Immunotherapy of Cancer (SITC) in November 2022, where he showcased his research findings.